These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Newborn screening for Krabbe disease: the New York State model. Duffner PK; Caggana M; Orsini JJ; Wenger DA; Patterson MC; Crosley CJ; Kurtzberg J; Arnold GL; Escolar ML; Adams DJ; Andriola MR; Aron AM; Ciafaloni E; Djukic A; Erbe RW; Galvin-Parton P; Helton LE; Kolodny EH; Kosofsky BE; Kronn DF; Kwon JM; Levy PA; Miller-Horn J; Naidich TP; Pellegrino JE; Provenzale JM; Rothman SJ; Wasserstein MP Pediatr Neurol; 2009 Apr; 40(4):245-52; discussion 253-5. PubMed ID: 19302934 [TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State. Wasserstein MP; Andriola M; Arnold G; Aron A; Duffner P; Erbe RW; Escolar ML; Estrella L; Galvin-Parton P; Iglesias A; Kay DM; Kronn DF; Kurtzberg J; Kwon JM; Langan TJ; Levy PA; Naidich TP; Orsini JJ; Pellegrino JE; Provenzale JM; Wenger DA; Caggana M Genet Med; 2016 Dec; 18(12):1235-1243. PubMed ID: 27171547 [TBL] [Abstract][Full Text] [Related]
4. Ethical issues with testing and treatment for Krabbe disease. Ehmann P; Lantos JD Dev Med Child Neurol; 2019 Dec; 61(12):1358-1361. PubMed ID: 31090922 [TBL] [Abstract][Full Text] [Related]
5. Weighing the evidence for newborn screening for early-infantile Krabbe disease. Kemper AR; Knapp AA; Green NS; Comeau AM; Metterville DR; Perrin JM Genet Med; 2010 Sep; 12(9):539-43. PubMed ID: 20601893 [TBL] [Abstract][Full Text] [Related]
6. Psychosine, a marker of Krabbe phenotype and treatment effect. Escolar ML; Kiely BT; Shawgo E; Hong X; Gelb MH; Orsini JJ; Matern D; Poe MD Mol Genet Metab; 2017 Jul; 121(3):271-278. PubMed ID: 28579020 [TBL] [Abstract][Full Text] [Related]
7. A prospective natural history study of Krabbe disease in a patient cohort with onset between 6 months and 3 years of life. Bascou N; DeRenzo A; Poe MD; Escolar ML Orphanet J Rare Dis; 2018 Aug; 13(1):126. PubMed ID: 30089515 [TBL] [Abstract][Full Text] [Related]
8. Newborn screening for Krabbe disease in New York State: the first eight years' experience. Orsini JJ; Kay DM; Saavedra-Matiz CA; Wenger DA; Duffner PK; Erbe RW; Biski C; Martin M; Krein LM; Nichols M; Kurtzberg J; Escolar ML; Adams DJ; Arnold GL; Iglesias A; Galvin-Parton P; Kronn DF; Kwon JM; Levy PA; Pellegrino JE; Shur N; Wasserstein MP; Caggana M; Genet Med; 2016 Mar; 18(3):239-48. PubMed ID: 26795590 [TBL] [Abstract][Full Text] [Related]
9. Consensus recommendations for the classification and long-term follow up of infants who screen positive for Krabbe Disease. Thompson-Stone R; Ream MA; Gelb M; Matern D; Orsini JJ; Levy PA; Rubin JP; Wenger DA; Burton BK; Escolar ML; Kurtzberg J Mol Genet Metab; 2021; 134(1-2):53-59. PubMed ID: 33832819 [TBL] [Abstract][Full Text] [Related]
10. Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months. Beltran-Quintero ML; Bascou NA; Poe MD; Wenger DA; Saavedra-Matiz CA; Nichols MJ; Escolar ML Orphanet J Rare Dis; 2019 Feb; 14(1):46. PubMed ID: 30777126 [TBL] [Abstract][Full Text] [Related]
11. Dangerous and expensive screening and treatment for rare childhood diseases: the case of Krabbe disease. Lantos JD Dev Disabil Res Rev; 2011; 17(1):15-8. PubMed ID: 22447750 [TBL] [Abstract][Full Text] [Related]
12. A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation. Escolar ML; Poe MD; Martin HR; Kurtzberg J Pediatrics; 2006 Sep; 118(3):e879-89. PubMed ID: 16923928 [TBL] [Abstract][Full Text] [Related]
14. The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York. Duffner PK; Caviness VS; Erbe RW; Patterson MC; Schultz KR; Wenger DA; Whitley C Genet Med; 2009 Jun; 11(6):450-4. PubMed ID: 19346954 [TBL] [Abstract][Full Text] [Related]
15. Development of a newborn screening tool based on bivariate normal limits: using psychosine and galactocerebrosidase determination on dried blood spots to predict Krabbe disease. Langan TJ; Orsini JJ; Jalal K; Barczykowski AL; Escolar ML; Poe MD; Biski CK; Carter RL Genet Med; 2019 Jul; 21(7):1644-1651. PubMed ID: 30546085 [TBL] [Abstract][Full Text] [Related]
17. Regional differences in fiber tractography predict neurodevelopmental outcomes in neonates with infantile Krabbe disease. Gupta A; Poe MD; Styner MA; Panigrahy A; Escolar ML Neuroimage Clin; 2015; 7():792-8. PubMed ID: 25844309 [TBL] [Abstract][Full Text] [Related]
18. Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease. Chuang WL; Pacheco J; Zhang XK; Martin MM; Biski CK; Keutzer JM; Wenger DA; Caggana M; Orsini JJ Clin Chim Acta; 2013 Apr; 419():73-6. PubMed ID: 23419961 [TBL] [Abstract][Full Text] [Related]
19. Why must the debate continue on Krabbe disease newborn screening? Pike-Langenfeld S Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):153-155. PubMed ID: 36056676 [TBL] [Abstract][Full Text] [Related]